How Biosimilar Drug Approvals Provide Opportunities for Pharmacists

May 7, 2015

Fred Eckel, RPh, MS, Editor-in-Chief of Pharmacy Times, reflects on how pharmacists will be affected by FDA approvals of biosimilars.

Fred Eckel, RPh, MS, Editor-in-Chief of Pharmacy Times, reflects on how pharmacists will be affected by FDA approvals of biosimilars.

This video was recorded at APhA’s Annual Meeting and Exposition in March 2015.